Vancouver, British Columbia, February 22, 2007 – Protox TM Therapeutics Inc. (TSX-V:PRX) today announced that it has granted 1,201,000 options pursuant to its previously approved stock option plan. The options were granted at an exercise price of $0.77 and will vest over three years. The Company also granted 225,000 options on February 5, 2007 at an exercise price of $0.64, some of which vest over three years and some of which will vest upon the achievement of milestones.
